Herman joined us in 2017 and focuses on life sciences investments. He has a strong background in public equity and buyout practice during his KPMG tenure where he primarily served CITIC Private Equity and Hillhouse Capital on their M&A quest to consolidate Chinese healthcare service providers. Herman was trained as a Biomedical Engineer from Tsinghua University with an MBA from Hong Kong University of Science and Technology. He is also a CICPA.